Description
Pharmacological action of
Gaviscon ® enters the stomach and interacts with its contents, forming a protective barrier (raft), which prevents the occurrence of heartburn.
Indications
Symptomatic treatment of dyspepsia, associated with increased acidity of gastric juice and gastroesophageal reflux (heartburn, sour belching), a feeling of heaviness in the stomach after eating, including during pregnancy.
Contraindications
Hypersensitivity to any of the components of the phenylketonuria drug (see section “Special instructions”) for children under 12 years of age.
Caution: If you have the following diseases or conditions, you should consult your doctor before using the drug: hypercalcemia, nephrocalcinosis and urolithiasis with the formation of calcium-oxalate stones, congestive heart failure, impaired renal function.
Special instructions
At a dose of four tablets, the sodium content is 246 mg (10.6 mmol). This should be taken into account if it is necessary to follow a diet with a very limited salt content, for example, in some cases of congestive heart failure and with impaired renal function.
Each dose of four tablets contains 320 mg (3.2 mmol) of calcium carbonate. Caution must be exercised in the treatment of patients with hypercalcemia, nephrocalciposis, and recurrent formation of kidney stones containing calcium. Due to the content of aspartame, this drug should not be prescribed to patients with phenylketonuria. There is a possibility of reducing the effectiveness of the drug in patients with very low levels of acidity of gastric juice. If after treatment within seven days the symptoms do not disappear, then a re-evaluation of the clinical condition is necessary.
Effect on the ability to drive mechanisms and a car
The drug does not affect the ability to drive vehicles and mechanisms, as well as on the activities of other potentially dangerous activities, requiring increased concentration of attention and speed of psychomotor reactions.
Composition
Active ingredients: sodium alginate 250 mg, sodium bicarbonate 133.5 mg, calcium carbonate 80 mg
Excipients: mannitol 255 mg, macrogol 20,000 30 mg, magnesium stearate 4 mg, aspartame 3.75 mg, copovidone 28 mg potassium acesulfame 3.75 mg, mint flavor 12 mg.
Dosage and administration
Inside, after thorough chewing. Adults and children over 12 years of age: 2-4 tablets after a meal and before bedtime (up to 4 times a day). If after 7 days of taking the drug the symptoms persist, you must consult a doctor to review therapy.
Side effects
Allergic reactions (urticaria, bronchospasm, anaphylactic reactions) are possible.
Overdose
Symptoms: Bloating may be noted.
Treatment: symptomatic.
Storage conditions
At a temperature not exceeding 30 ° C. Keep out of the reach of children.
Expiration
2 years.
Do not use after expiration date.
Terms and conditions
without prescription
Reckitt Benquizer, United Kingdom
